United Kingdom

People: Chembio Diagnostics Inc (CEMI.OQ)

CEMI.OQ on NASDAQ Stock Exchange Capital Market

16 Aug 2019
Change (% chg)

$0.07 (+1.29%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low

Sperzel, John 

Mr. John J. Sperzel, III, is President, Chief Executive Officer, Director of Chembio Diagnostics, Inc. Mr. Sperzel was appointed Chief Executive Officer and President of Chembio Diagnostics, Inc. and a member of our Board in March 2014. Prior to joining the Company, Mr. Sperzel, was the President and CEO of International Technidyne Corporation (ITC) from September 2011 to December 2013. Mr. Sperzel served as President at Axis-Shield from September 2004 to September 2011. He also has held senior leadership positions at Bayer Diagnostics (Siemens Dx), Instrumentation Laboratory, and Boehringer Mannheim Diagnostics (Roche Dx). Mr. Sperzel graduated from Plymouth State College in New Hampshire, with a B.S. in Business Administration/Management. He currently serves as an advisor to the board of the Diagnostic Marketing Association, and was the president of the board of that Association in 2007. Mr. Sperzel's knowledge of, and experience in, the Company's specific business and its industry sector, together with the continuing current knowledge that he is accumulating about the Company in his position as CEO of the Company, made him an excellent candidate for serving on the Board.

Basic Compensation

Total Annual Compensation, USD 298,558
Restricted Stock Award, USD --
Long-Term Incentive Plans, USD --
All Other, USD 669,625
Fiscal Year Total, USD 968,183

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --